Generic Medicine and Generic Prescribing in Nepal: An Implication for Policymakers

References

• Ministry of Health and Population. MoHP. National Health Policy 2019, Government of Nepal. 2019:76.
   Google Scholar
• DDA. National drug policy−1995, Department of Drug Administration, Nepal; 1995. Available from: http://www.dda.gov.np/content/national-drug-policy-1995. Accessed January 7, 2022.
   Google Scholar
• Government of Nepal. The constitution of Nepal 2015. Nepal Gaz. 2015;2015:Art.58.
   Google Scholar
• United Nations HumanRrights. Access to medicines - a fundamental element of the right to health. Available from: https://www.ohchr.org/en/issues/development/pages/accesstomedicines.aspx. Accessed June 3, 2021.
   Google Scholar
• Ministry of Health and Population. Nepal national health accounts 2012/13 to 2015/16, Government of Nepal; 2018:123. Available from: www.searo.who.int/entity/nepal/documents/nepal_nha_2012_13_2015_16_mohp_june_2018.pdf. Accessed January 7, 2022.
   Google Scholar
• Global spending on health: a world in transition; 2019. Available from: https://www.who.int/publications/i/item/WHO-HIS-HGF-HFWorkingPaper-19.4. Accessed June 3, 2021.
   Google Scholar
• Aryal A, Dahal A, Shrestha R. Study on drug use pattern in primary healthcare centers of Kathmandu valley. SAGE Open Med. 2020;8:205031212092643. doi:10.1177/2050312120926437
   Web of Science ®Google Scholar
• Karki KB, Aryal KK, Gyawali P, et al. Quality of drugs and drug use patterns at different level of health care settings in Nepal; 2017. Available from: http://nhrc.gov.np/wp-content/uploads/2017/11/Final_Drug.pdf. Accessed January 7, 2022.
   Google Scholar
• Government of Nepal. Free essential drug for health institution. Available from: https://www.publichealthupdate.com/list-of-free-essential-drugs-for-health-institutions-nepal/. Accessed January 7, 2022.
   Google Scholar
• Ide N, LoGerfo JP, Karmacharya B. Barriers and facilitators of diabetes services in Nepal: a qualitative evaluation. Health Policy Plan. 2018;33(4):474–482. doi:10.1093/heapol/czy011
   PubMed Web of Science ®Google Scholar
• Hassali MA, Alrasheedy AA, McLachlan A, et al. The experiences of implementing generic medicine policy in eight countries: a review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J. 2014;22(6):491–503. doi:10.1016/j.jsps.2013.12.017
   PubMed Web of Science ®Google Scholar
• Pharmaphorum. How generic medicines increase patient access to treatment; 2020. Available from: https://pharmaphorum.com/views-and-analysis/how-generic-medicines-increase-patient-access-to-treatment/. Accessed December 11, 2021.
   Google Scholar
• Gashaw T, Sisay M, Mengistu G, Amare F. Investigation of prescribing behavior at outpatient settings of governmental hospitals in eastern Ethiopia: an overall evaluation beyond World Health Organization core prescribing indicators. J Pharm Policy Pract. 2018;11(1):1–11. doi:10.1186/S40545-018-0152-Z/TABLES/7
   PubMedGoogle Scholar
• Yilma Z, Liben M. Assessment of drug prescription pattern in Mekelle General Hospital, Mekelle, Ethiopia, using World Health Organization prescribing indicators. Biomed Res Int. 2020;2020:1–6. doi:10.1155/2020/3809157
   Web of Science ®Google Scholar
• Gupta SK, Nayak RP, Vidyarthi SK, et al. KAP of generic medicines among doctors. Natl J Physiol Pharm Pharmacol. 2015;5:39–44. doi:10.5455/njppp.2015.5.170720141
   Google Scholar
• Najmi MH, Hafiz RA, Khan I, Fazli FR. Prescribing practices: an overview of three teaching hospitals in Pakistan. Pakistan Medical Assoc. 1998;48(3):73–77
   PubMedGoogle Scholar
• Aravamuthan A, Arputhavanan M, Subramaniam K, et al. Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India. J Pharm Policy Pract. 2016;10(1):1–6. doi:10.1186/S40545-016-0074-6/TABLES/6
   PubMedGoogle Scholar
• Atif M, Malik I, Mushtaq I, et al. Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers. BMJ Open. 2019;9(9):e027028. doi:10.1136/BMJOPEN-2018-027028
   PubMed Web of Science ®Google Scholar
• Malik A. Prescribe medicines with generic and not brand names, DRAP tells Pakistan’s doctors; 2021. Available from: https://www.geo.tv/latest/346083-prescribe-medicines-with-generic-and-not-brand-names-drap-tells-pakistans-doctors. Accessed December 13, 2021.
   Google Scholar
• World Health Organization.WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization Technical Report Series. 1993:834.
   Google Scholar
• Desai RJ, Sarpatwari A, Dejene S, et al. Comparative effectiveness of generic and brand-name medication use: a database study of us health insurance claims. PLoS Med. 2019;16(3):e1002763. doi:10.1371/journal.pmed.1002763
   PubMed Web of Science ®Google Scholar
• Tian Y, Reichardt B, Dunkler D, et al. Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study. Sci Rep. 2020;10(1):1–12. doi:10.1038/s41598-020-62318-y
   PubMed Web of Science ®Google Scholar
• Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, et al. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012;15(5):664–673. doi:10.1016/j.jval.2012.04.004
   PubMed Web of Science ®Google Scholar
• Baumgärtel C. Myths, questions, facts about generic drugs in the EU. Generics Biosimilars Initiat J. 2012;1(1):34–38. doi:10.5639/gabij.2012.0101.009
   Google Scholar
• Ministry of Health and Population. Drug Bulletin of Nepal, Department of Drug Administration, Nepal. Ministry of Health and Population. 2018:29.
   Google Scholar
• Aarthiknews. Govt to fix medicine price, generic name of medicine obligatory. Available from: http://english.aarthiknews.com/11188-2govt-to-fix-medicine-price-generic-name-of-medicine-obligatory. Accessed June 3, 2021.
   Google Scholar
• DDA. Role of DDA, Department of Drug Administration, Nepal. Available from: https://www.dda.gov.np/content/role-of-dda. Accessed June 3, 2021.
   Google Scholar
• Pandey PJ. Generic medicine is the future - the Himalayan times. Available from: https://thehimalayantimes.com/blogs/generic-medicine-is-the-future. Accessed June 11, 2021.
   Google Scholar
• The Rising Nepal. TRIPS transition period for LDC extended till 2034; 2021. Available from: https://risingnepaldaily.com/main-news/trips-transition-period-for-ldc-extended-till-2034. Accessed October 23, 2021.
   Google Scholar
• Khanal DP, Adhikari P, Chapagain S, et al. Generic prescribing, brand and generic substitution, availability and cost effectiveness of the available medicines. J Manmohan Meml Inst Health Sci. 2018;4(1):33–42. doi:10.3126/jmmihs.v4i1.21142
   Google Scholar
• Shankar PR, Hassali MA, Subish P, et al. GenMed 010: a one day workshop on generic medicines. Australas Med J. 2011;4(3):133–135. doi:10.4066/AMJ.2011.587
   PubMedGoogle Scholar
• Shrestha R, Prajapati S. Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal. J Pharm Policy Pract. 2019;12(1):16. doi:10.1186/s40545-019-0177-y
   PubMedGoogle Scholar
• Hema Nagadurga D. Bioavailability and bioequivalence studies. In: Pharmaceutical Formulation Design - Recent Practices. IntechOpen; 2020. doi10.5772/intechopen.85145
   Google Scholar
• DDA. Medicine registration guidance 2073, Department of Drug Administration, Nepal; 2016. Available from: https://pharmainfonepal.com/wp-content/uploads/2020/12/Medicine-registration-guidance-2073.pdf. Accessed August 23, 2021.
   Google Scholar
• DDA. Drug registration regulation 2038, Department of Drug Administration, Nepal. Available from: https://www.dda.gov.np/content/drug-registration-regulation-2038. Accessed June 3, 2021.
   Google Scholar
• NMC. Nepal medical council code of ethics. Nepal Medical Council; 2017. Available from: https://nmc.org.np/nmc-code-of-ethics. Accessed January 7, 2022.
   Google Scholar
• Republic S, France I. Share of generic market for pharmaceuticals. Health A Glance Eur. 2016;1(2):182–183. doi:10.1787/health_glance_eur-2016-64-en
   Google Scholar
• Dylst P, Vulto A, Simoens S. Demand-side policies to encourage the use of generic medicines: an overview. Expert Rev Pharmacoeconomics Outcomes Res. 2013;13(1):59–72. doi:10.1586/erp.12.83
   PubMed Web of Science ®Google Scholar
• Mostafa S, Mohammad MA, Ebrahim J. Policies and practices catalyzing the use of generic medicines: a systematic search and review. Ethiop J Health Sci. 2021;31(1):167–178. doi:10.4314/ejhs.v31i1.19
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Population. Nepal pharmaceutical country profile. Government of Nepal; 2011. Available from: https://www.who.int/medicines/areas/coordination/nepal_pharmaceutical_profile.pdf. Accessed June 16, 2021.
   Google Scholar
• Paveliu MS, Bengea S, Paveliu FS. Generic substitution issues: brand-generic substitution, generic-generic substitution, and generic substitution of narrow therapeutic index (NTI)/critical dose drugs. Mædica. 2011;6(1):52.
   PubMedGoogle Scholar
• Macdougall IC, Casadevall N, Locatelli F, et al. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS). Nephrol Dial Transplant. 2015;30(3):451. doi:10.1093/NDT/GFU297
   PubMed Web of Science ®Google Scholar
• The Kathmandu Post. Maharajgunj Medical Campus to have drug quality test centre. Available from: https://kathmandupost.com/national/2018/12/31/maharajgunj-medical-campus-to-have-drug-quality-test-centre. Accessed August 7, 2020.
   Google Scholar
• Stewart K, Alrasheedy A, Hassali A, et al. Patient knowledge, perceptions, and acceptance of generic medicines: a comprehensive review of the current literature. Patient Intell. 2014;49(14):1. doi:10.2147/pi.s46737
   Google Scholar
• Giri BR, Shankar PR. Learning how drug companies promote medicines in Nepal: an educational initiative looks critically at the drug industry’s promotional tactics. PLoS Med. 2005;2(8):0710–0711. doi:10.1371/journal.pmed.0020256
   Web of Science ®Google Scholar
• Budhathoki SS, Pokharel PK, Good S, et al. The potential of health literacy to address the health related UN sustainable development goal 3 (SDG3) in Nepal: a rapid review. BMC Health Serv Res. 2017;17(1):1–13. doi:10.1186/s12913-017-2183-6
   PubMed Web of Science ®Google Scholar
• Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13:1. doi:10.1186/s12916-015-0415-3
   PubMed Web of Science ®Google Scholar
• Gyawali S, Hassali MA, Saha A. A survey exploring the knowledge and perceptions of senior medical students in Nepal toward generic medicines. SAGE Open Med. 2016;4:205031211666257. doi:10.1177/2050312116662570
   Google Scholar
• Gyanwali P, Humagain BR, Aryal KK, et al. Surveillance of quality of medicines available in the Nepalese market: a study from Kathmandu valley. J Nepal Health Res Counc. 2015;13(31):233–240.
   PubMedGoogle Scholar
• Neupane A, Bastakoti M, Tamang S, et al. Incidences of poor-quality pharmaceutical products in Nepal [Preprint]. medRxiv. 2021. doi:10.1101/2021.04.15.21255541
   Google Scholar
• USFDA. Generic Drugs: Questions & Answers. United States Food and Drug Administration. Available from: https://www.fda.gov/drugs/questions-answers/generic-drugs-questions-answers#q2
   Google Scholar
• myReupublica. Govt indifferent to restructuring and empowering DDA in federalism, the Republica Daily. Available from: https://myrepublica.nagariknetwork.com/news/govt-indifferent-to-restructuring-and-empowering-dda-in-federalism/. Accessed June 11, 2021.
   Google Scholar
• Colgan S, Faasse K, Martin LR, et al. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open. 2015;5:12. doi:10.1136/bmjopen-2015-008915
   Web of Science ®Google Scholar
• Ghimire S, Nepal S, Bhandari S, et al. A prospective surveillance of drug prescribing and dispensing in a teaching hospital in western Nepal. J Pak Med Assoc. 2009;59(10):726–731.
   PubMedGoogle Scholar
• Ansari M, Humagain B, Hassali MA. Generic medicines utilizations and generic prescribing in Nepal: a reflection of current scenario and possible solutions. Res Soc Adm Pharm. 2017;13(3):658–659. doi:10.1016/j.sapharm.2017.01.004
   PubMed Web of Science ®Google Scholar
• Napit PR. Promotional efforts of pharmaceutical industries on prescribing pattern of antibiotics among medical doctors in Nepal. J Bus Soc Sci Res. 2018;1(2):201. doi:10.3126/jbssr.v1i2.20925
   Google Scholar
• Harper I, Rawal N, Subedi M. Disputing distribution: ethics and pharmaceutical regulation in Nepal. Stud Nepali Hist Soc. 2011;16(1):1–39.
   Google Scholar
• Jha N, Sapkota Y, Shankar PR. Critical evaluation of drug advertisements in a medical college in Lalitpur, Nepal. J Multidiscip Healthc. 2020;13:717–725. doi:10.2147/JMDH.S259708
   PubMed Web of Science ®Google Scholar
• Alam K, Shah AK, Ojha P, et al. Evaluation of drug promotional materials in a hospital setting in Nepal. South Med Rev. 2009;2(1):2–6.
   PubMedGoogle Scholar
• Lee Ventola C. Direct-to-consumer pharmaceutical advertising therapeutic or toxic? P T. 2011;36(10):669–684.
   PubMedGoogle Scholar
• Shrestha S, Khatiwada AP, Gyawali S, Shankar PR, Palaian S. Overview, Challenges and Future Prospects of Drug Information Services in Nepal: A Reflective Commentary. J Multidiscip Healthc. 2020;13:287-295 https://doi.org/10.2147/JMDH.S238262.
   Google Scholar
• Razmaria AA. Generic drugs. JAMA. 2016;315(24):2746. doi:10.1001/jama.2016.3990
   PubMedGoogle Scholar
• USFDA. Generic drug facts. United States Food and Drug Administration. Available from: https://www.fda.gov/drugs/generic-drugs/generic-drug-facts. Accessed August 7, 2020.
   Google Scholar
• DDA. Hospital Pharmacy Guideline 2072, Department of Drug Administration, Nepal; 2015. Available from: https://www.dda.gov.np/content/hospital-pharmacy-guideline-2072. Accessed August 23, 2021.
   Google Scholar
• WHO. Drug and Therapeutics Committees A Practical Guide, World Health Organiztion; 2003. Available from: https://apps.who.int/iris/bitstream/handle/10665/68553/WHO_EDM_PAR_2004.1.pdf?sequence=1&isAllowed=y.
   Google Scholar